Singapore Firm To Develop Promising Ebola Vaccine For Clinical Trials
Singapore Firm to Develop Promising Ebola Vaccine for Clinical Trials Hilleman Laboratories, a Singapore-based vaccine research organization, has been selected to develop and manufacture doses of one of the world’s most promising experimental vaccines against the Bundibugyo strain of the Ebola virus for use in early-stage clinical trials. The initiative is being supported by the […]
READ MORE